Caerus Biotechnologies - Company finances
- The company is late in submitting financial data for the previous financial year.
- Latest financial data up to 2024-12-31.
|
EUR
|
2021
From: 2021-06-28
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | 243,387 | 1,110,464 | 1,116,963 | 1,039,193 |
| Profit before tax | - | - | 22,784 | 66,823 |
| Net profit | -26,903 | -226,238 | 20,628 | 63,419 |
| Equity | -6,903 | -233,141 | -212,513 | -149,094 |
| Liabilities | 717,469 | 1,069,278 | 1,245,813 | 1,319,331 |
| Non-current assets | 366,542 | 233,254 | 109,111 | 11,723 |
| Current assets | 343,627 | 662,738 | 946,558 | 1,163,221 |
| Total assets | 710,169 | 895,992 | 1,055,669 | 1,174,944 |
|
Taxes paid
|
||||
| STI taxes | - | - | 39,033 | 11,603 |
| Social insurance contributions | - | - | - | - |
|
Financial indicators
|
||||
| Revenue change y/y | - | +356.3% | +0.6% | -7.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -3.8% | -25.3% | 2.0% | 5.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -11.1% | -20.4% | 1.8% | 6.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | 2.0% | 6.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 68,149 | 360,154 | 446,785 | 346,398 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Caerus Biotechnologies - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-04-30 | 2025-04-30 | 0.01 |
| 2025-04-16 | 2025-04-27 | 0.01 |
| 2025-03-18 | 2025-03-30 | 0.01 |
| 2025-03-03 | 2025-03-03 | 0.01 |
| 2025-02-18 | 2025-02-27 | 0.01 |
| 2025-02-10 | 2025-02-10 | 0.01 |
| 2025-01-22 | 2025-01-30 | 0.01 |
| 2024-10-16 | 2024-10-20 | 5.60 |
| 2024-05-16 | 2024-05-30 | 2.73 |
| 2024-04-23 | 2024-04-29 | 2.73 |
| 2024-03-18 | 2024-03-25 | 827.63 |
Caerus Biotechnologies - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-01-29 | 2026-01-29 | 5408.63 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.